CD4 and cancer: More recently, a pancancer scRNA-Seq atlas of CD4+ and CD8+ T cells compiled across 21 human cancer types by Zheng et al. revealed a dominant intratumoral Treg population annotated as TNFRSF9+, which was present at lower frequencies in nonaffected NLT and even less in peripheral blood (58).